Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,114,900 | 3,700,400 | 1,495,700 | 1,947,500 | 813,700 |
| Marketable Securities | 503,300 | 135,600 | 101,400 | 77,100 | 141,400 |
| Receivables | 1,966,100 | 1,842,800 | 2,243,700 | 1,544,300 | 1,474,600 |
| Inventories | 883,100 | 899,600 | 999,900 | 900,700 | 881,400 |
| Income taxes - deferred | 269,500 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 477,100 | 566,100 | 851,100 | 580,200 |
| TOTAL | $7,943,000 | $7,055,500 | $5,406,800 | $5,320,700 | $3,891,300 |
| Non-Current Assets | |||||
| PPE Net | 4,176,600 | 3,981,500 | 4,096,300 | 4,101,700 | 4,307,000 |
| Investments And Advances | 395,700 | 180,300 | 204,000 | 465,600 | 443,500 |
| Other Non-Current Assets | 2,175,500 | 1,607,900 | 2,888,400 | 2,689,400 | 5,665,400 |
| TOTAL | $6,747,800 | $5,769,700 | $7,188,700 | $7,256,700 | $10,415,900 |
| Total Assets | $14,690,800 | $12,825,200 | $12,595,500 | $12,577,400 | $14,307,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 184,300 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 661,900 | 445,500 | 1,186,000 | 985,500 | 829,300 |
| Accrued Expenses | N/A | 489,300 | 704,000 | 456,600 | 388,400 |
| Other current liabilities | 1,598,900 | 1,313,800 | 1,245,600 | 1,333,900 | 1,099,800 |
| TOTAL | $4,960,700 | $3,935,400 | $4,607,200 | $4,191,600 | $4,222,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,633,700 | 2,811,900 | 2,185,500 | 2,326,100 | 2,516,500 |
| Other Non-Current Liabilities | 1,049,500 | 927,900 | 1,125,300 | 1,198,600 | 1,092,400 |
| TOTAL | $3,683,200 | $3,876,800 | $3,558,700 | $3,740,200 | $3,984,900 |
| Total Liabilities | $8,643,900 | $7,812,200 | $8,165,900 | $7,931,800 | $8,207,100 |
| Shareholders' Equity | |||||
| Common Shares | 704,400 | 682,000 | 686,500 | 694,700 | 355,600 |
| Retained earnings | 6,223,200 | 4,985,600 | 4,228,800 | 4,483,100 | 7,207,300 |
| Other shareholders' equity | -3,380,700 | -546,600 | -376,700 | -422,200 | -234,200 |
| TOTAL | $6,046,900 | $5,013,000 | $4,429,600 | $4,645,600 | $6,100,100 |
| Total Liabilities And Equity | $14,690,800 | $12,825,200 | $12,595,500 | $12,577,400 | $14,307,200 |